Competition and innovation in the EU regulation of pharmaceuticals: The Case of Parallel Trade

Claudia Desogus

This section selects books on themes related to competition laws and economics. This compilation does not attempt to be exhaustive but rather a survey of themes important in the area. The survey usually covers publication over the last three months after publication of the latest issue of Concurrences. Publishers, authors and editors are welcome to send books to catherine.prieto@univ-paris1.fr for review in this section.

This book deals with parallel trade of pharmaceuticals from a Law & Economics perspective. In recent judgments (Bayer, Glaxo and Syfait), EU Courts questioned some of the legal principles underpinning the EU policy on parallel trade in the field of pharmaceuticals. Through the analysis of the impact that parallel trade of pharmaceuticals has on consumer welfare, both in a static and in a dynamic sense, this work examines whether the current legal approach to parallel trade of pharmaceuticals reflects the findings of economic theory, whether it should change, and, if so, on what basis this adjustment should take place.

Author

  • Italian Competition Authority (Rome)

Quotation

Claudia Desogus, Competition and innovation in the EU regulation of pharmaceuticals: The Case of Parallel Trade, February 2011, Concurrences N° 1-2011, Art. N° 109939

Publisher Intersentia

Date 13 December 2010

Number of pages 342

ISBN 9789400001473

Visites 56

All reviews